Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106478725A reveals advanced recrystallization for TAF intermediates. Ensures over 99.5 percent optical purity and scalable manufacturing for global supply chains.
Discover a novel high-yield synthesis for Obeticholic Acid intermediates via Weinreb amide protection. Enhance purity to 99.9% and reduce manufacturing costs significantly.
Patent CN118515620A details a heterogeneous Pd/ACFs catalytic method for high-purity quinazolinone synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel immobilized cell method ensures high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Novel lipase mutant enables efficient synthesis of chiral intermediates. Reduces solvent use and enhances supply chain reliability for global pharmaceutical manufacturing.
Patent CN114380902B details fragment condensation for HGH 176-191. Enhances purity and supply chain stability for pharmaceutical intermediates.
Patent CN105152966A details a novel azide preparation method offering improved control and scalability for pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN103468757A details a green enzymatic reduction for Atazanavir intermediates, offering high purity and safer manufacturing for pharmaceutical supply chains.
Patent CN105566398B reveals novel rhodium complex synthesis. Delivers enhanced antitumor activity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Novel patent method for azido phenetole intermediate ensures high purity and scalable production. Reduces complexity in pharmaceutical manufacturing supply chains significantly.
Novel synthetic route for Gefitinib intermediates utilizing cheap raw materials, mild conditions, and avoiding toxic chlorinating agents for cost-effective production.
Advanced synthesis of P1,P4-di(uridine-5'-) tetraphosphate via metal-catalyzed coupling. Achieves high purity, low metal residue, and cost reduction in API manufacturing.
Patent CN103232467B reveals novel Sinomenine modifications offering superior anti-inflammatory activity and scalable synthesis for global pharmaceutical supply chains.
Novel 2-phenyl quinazoline derivatives targeting telomerase with high selectivity and low toxicity. Efficient synthesis routes for pharmaceutical intermediates.
Novel two-step synthesis from Michelactone offers high yield and scalability for Arglabin production reducing costs and ensuring supply chain reliability for oncology drug manufacturers
Novel one-pot method for (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone. High purity, reduced steps, eco-friendly process for API manufacturing.
Patent CN106905177A details high-yield synthesis for AHU-377 intermediate. Offers cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Novel one-pot method for pregnenolone derivatives using Oxone. Eliminates chromium waste, offers mild conditions, and ensures high-purity steroid intermediates for scalable API manufacturing.
Patent CN1182125C details a robust route for (2R,2-alpha-R,3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine, offering superior yield and purity for pharmaceutical supply chains.
Patent CN1487916A details an improved method for beta-3 agonist intermediates, offering higher yields and streamlined manufacturing for reliable pharmaceutical suppliers.